Publications - Lyme Disease


Lovrich SD, Jobe DA, Kowalski TJ, Policepatil SM, Callister SM. Expansion of the Midwestern focus for human granulocytic anaplasmosis into the region surrounding La Crosse, Wisconsin. J Clin Microbiol. 2011 Nov;49(11):3855-3859. PMCID: PMC3209085.
Abstract

Kuo J, Nardelli DT, Warner TF, Callister SM, Schell RF. Interleukin-35 enhances Lyme arthritis in Borrelia-vaccinated and -infected mice. Clin Vaccine Immunol. 2011 Jul;18(7):1125-1132. PMCID:PMC3147320.
Abstract

Jobe DA, Kowalski TJ, Bloemke M, Lovrich SD, Callister SM. Rapid decline of OspC borreliacidal antibodies following treatment of patients with early Lyme disease. Clin Vaccine Immunol. 2011 Jun;18(6):1034-1037. PMCID:PMC3122617.
Abstract

Nardelli DT, Luedtke JO, Munson EL, Warner TF, Callister SM, Schell RF. Significant differences between the Borrelia-infection and Borrelia-vaccination and -infection models of Lyme arthritis in C3H/HeN mice. FEMS Immunol Med Microbiol. 2010 Oct;60(1):78-89.
Abstract

LaFleur RL, Callister SM, Dant JC, Jobe DA, Lovrich SD, Warner TF, Wasmoen TL, Schell RF. One-year duration of immunity induced by vaccination with a canine Lyme disease bacterin. Clin Vaccine Immunol. 2010 May;17(5):870-874. PMCID: PMC2863397.
Abstract

Little SE, Heise SR, Blagburn BL, Callister SM, Mead PS. Lyme borreliosis in dogs and humans in the USA. Trends Parasitol. 2010 Apr;26(4):213-218.
Abstract

Nardelli DT, Munson EL, Callister SM, Schell RF. Human Lyme disease vaccines: past and future concerns. Future Microbiol. 2009 May;4(4):457-69.
Abstract

LaFleur RL, Dant JC, Wasmoen TL, Callister SM, Jobe DA, Lovrich SD, Warner TF, Abdelmagid O, Schell RF. Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease. Clin Vaccine Immunol. 2009 Feb;16(2):253-259. PMCID: PMC2643534.
Abstract

Callister SM, Jobe DA, Schell RF. Detection of borreliacidal antibodies by flow cytometry. Curr Protoc Cytom. 2004 Nov;Chapter 11:Unit 11.5.
Abstract

Kotloski NJ, Nardelli DT, Peterson SH, Torrealba JR, Warner TF, Callister SM, Schell RF. Interleukin-23 is required for development of arthritis in mice vaccinated and challenged with Borrelia species. Clin Vaccine Immunol. 2008 Aug;15(8):1199-1207. PMCID: PMC2519303.
Abstract

Nardelli DT, Kevin Luk KH, Kotloski NJ, Warner TF, Torrealba JR, Callister SM, Schell RF. Role of IL-17, transforming growth factor-β, and IL-6 in the development of arthritis and production of anti-outer surface protein A borreliacidal antibodies in Borrelia-vaccinated and -challenged mice. FEMS Immunol Med Microbiol. 2008 Jul;53(2):265-274.
Abstract

Jobe DA, Lovrich SD, Asp KE, Mathiason MA, Albrecht SE, Schell RF, Callister SM. Significantly improved accuracy of diagnosis of early Lyme disease by peptide enzyme-linked immunosorbent assay based on the borreliacidal antibody epitope of Borrelia burgdorferi OspC. Clin Vaccine Immunol. 2008 Jun;15(6):981-985. PMCID: PMC2446615.
Abstract

Nardelli DT, Callister SM, Schell RF. Lyme arthritis: current concepts and a change in paradigm. Clin Vaccine Immunol. 2008 Jan;15(1):21-34. PMCID: PMC2223850.
Article

Peterson SH, Nardelli DT, Warner TF, Callister SM, Torrealba JR, Schell RF. Anti-p19 antibody treatment exacerbates Lyme arthritis and enhances borreliacidal activity. Clin Vaccine Immunol. 2007 May;14(5):510-517. PMCID: PMC1865634.
Abstract

Lovrich SD, LaFleur RL, Jobe DA, Johnson JC, Asp KE, Schell RF, Callister SM. Borreliacidal OspC antibody response of canines with Lyme disease differs significantly from that of humans with Lyme disease. Clin Vaccine Immunol. 2007 May;14(5):635-637. PMCID: PMC1865635.
Abstract

Jobe DA, Nelson JA, Adam MD, Martin SA,Jr. Lyme disease in urban areas, Chicago. Emerg Infect Dis. 2007;13(11):1799-1800.
Link

Nardelli DT, Warner TF, Callister SM, Schell RF. Anti-CD25 antibody treatment of mice vaccinated and challenged with Borrelia spp. does not exacerbate arthritis but inhibits borreliacidal antibody production. Clin Vaccine Immunol. 2006 Aug; 13(8): 884-891. PMCID: PMC1539113.
Abstract

Jobe DA, Lovrich SD, Nelson JA, Velat TC, Anchor C, Koeune T, Martin SA,Jr. Borrelia burgdorferi in Ixodes scapularis ticks, Chicago area. Emerg Infect Dis. 2006 Jun;12(6):1039-1041.

Amlong CA, Nardelli DT, Peterson SH, Warner TF, Callister SM, Schell RF. Anti-interleukin-15 prevents arthritis in Borrelia-vaccinated and -infected mice. Clin Vaccine Immunol. 2006 Feb;13(2):289-296. PMCID: PMC1391944.
Abstract

Munson EL, Nardelli DT, Luk KH, Remington MC, Callister SM, Schell RF. Interleukin-6 promotes anti-OspA borreliacidal antibody production in vitro. Clin Vaccine Immunol. 2006 Jan;13(1):19-25. PMCID: PMC1356618.
Abstract

Nardelli DT, Cloute JP, Luk KH, Torrealba J, Warner TF, Callister SM, Schell RF. CD4(+) CD25(+) T cells prevent arthritis associated with Borrelia vaccination and infection. Clin Diagn Lab Immunol. 2005 Jun;12(6):786-792. PMCID: PMC1151965.
Abstract

Lovrich SD, Jobe DA, Schell RF, Callister SM. Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human Lyme disease and do not occur in mice or hamsters. Clin Diagn Lab Immunol. 2005 Jun;12(6):746-751. PMCID: PMC1151971.
Abstract

Nardelli DT, Burchill MA, England DM, Torrealba J, Callister SM, Schell RF. Association of CD4+ CD25+ T cells with prevention of severe destructive arthritis in Borrelia burgdorferi-vaccinated and challenged gamma interferon-deficient mice treated with anti-interleukin-17 antibody. Clin Diagn Lab Immunol. 2004 Nov;11(6):1075-1084. PMCID: PMC524754.
Abstract

Munson EL, DeCoster DJ, Nardelli DT, England DM, Callister SM, Schell RF. Neutralization of gamma interferon augments borreliacidal antibody production and severe destructive Lyme arthritis in C3H/HeJ mice. Clin Diagn Lab Immunol. 2004 Jan;11(1):35-41. PMCID: PMC321347.
Abstract

Jobe DA, Lovrich SD, Schell RF, Callister SM. C-terminal region of outer surface protein C binds borreliacidal antibodies in sera from patients with Lyme disease. Clin Diagn Lab Immunol. 2003 Jul;10(4):573-578.
Abstract

Burchill MA, Nardelli DT, England DM, DeCoster DJ, Christopherson JA, Callister SM, Schell RF. Inhibition of interleukin-17 prevents the development of arthritis in vaccinated mice challenged with Borrelia burgdorferi. Infect Immun. 2003 Jun;71(6):3437-3442. PMCID: PMC155727.
Abstract

Christopherson JA, Munson EL, England DM, Croke CL, Remington MC, Molitor ML, DeCoster DJ, Callister SM, Schell RF. Destructive arthritis in vaccinated interferon gamma-deficient mice challenged with Borrelia burgdorferi: Modulation by tumor necrosis factor alpha. Clin Diagn Lab Immunol. 2003 Jan;10(1):44-52. PMCID: PMC145283.
Abstract

Munson EL, DuChateau BK, Jensen JR, Callister SM, DeCoster DJ, Schell RF. Gamma interferon inhibits production of anti-OspA borreliacidal antibody in vitro. Clin Diagn Lab Immunol. 2002 Sep;9(5):1095-1101. PMCID: PMC120068.
Abstract

Callister SM, Jobe DA, Agger WA, Schell RF, Kowalski TJ, Lovrich SD, Marks JA. Ability of the borreliacidal antibody test to confirm Lyme disease in clinical practice. Clin Diagn Lab Immunol. 2002 Jul;9(4):908-912. PMCID: PMC120016.
Abstract

Jackson CA, Lovrich SD, Agger WA, Callister SM. Reassessment of a midwestern Lyme disease focus for Borrelia burgdorferi and the human granulocytic ehrlichiosis agent. J Clin Microbiol. 2002 Jun;40(6):2070-2073. PMCID: PMC130725.
Abstract

Remington MC, Munson EL, Callister SM, Molitor ML, Christopherson JA, DeCoster DJ, Lovrich SD, Schell RF. Interleukin-6 enhances production of anti-OspC immunoglobulin G2b borreliacidal antibody. Infect Immun. 2001 Jul;69(7):4268-4275. PMCID: PMC98496.
Abstract

Callister SM, Jobe DA, Schell RF, Lovrich SD, Onheiber KL, Korshus JB. Detection of borreliacidal antibodies in dogs after challenge with Borrelia burgdorferi-infected Ixodes scapularis ticks. J Clin Microbiol. 2000 Oct;38(10):3670-3674. PMCID: PMC87454.
Abstract

Munson EL, DuChateau BK, Jobe DA, Lovrich SD, Callister SM, Schell RF. Production of borreliacidal antibody to outer surface protein A in vitro and modulation by interleukin-4. Infect Immun. 2000 Oct;68(10):5496-5501. PMCID: PMC101497.
Abstract

Croke CL, Munson EL, Lovrich SD, Christopherson JA, Remington MC, England DM, Callister SM, Schell RF. Occurrence of severe destructive Lyme arthritis in hamsters vaccinated with outer surface protein A and challenged with Borrelia burgdorferi. Infect Immun. 2000 Feb;68(2):658-663. PMCID: PMC97189.
Abstract

Wieneke CA, Lovrich SD, Callister SM, Jobe DA, Marks JA, Schell RF. Evaluation of whole-cell and OspC enzyme-linked immunosorbent assays for discrimination of early Lyme borreliosis from OspA vaccination. J Clin Microbiol. 2000 Jan;38(1):313-317. PMCID: PMC88715.
Abstract

Jobe DA, Rawal N, Schell RF, Callister SM. Detection of borreliacidal antibodies in Lyme borreliosis patient sera containing antimicrobial agents. Clin Diagn Lab Immunol. 1999 Nov;6(6):930-933. PMCID: PMC95800.
Abstract

DuChateau BK, Munson EL, England DM, Lovrich SD, Callister SM, Jensen JR, Schell RF. Macrophages interact with enriched populations of distinct T lymphocyte subsets for the induction of severe destructive Lyme arthritis. J Leukoc Biol. 1999 Feb;65(2):162-170.
Abstract

Rousselle JC, Callister SM, Schell RF, Lovrich SD, Jobe DA, Marks JA, Wieneke CA. Borreliacidal antibody production against outer surface protein C of Borrelia burgdorferi. J Infect Dis. 1998 Sep;178(3):733-741.
Abstract

Jensen JR, DuChateau BK, Munson EL, Callister SM, Schell RF. Inhibition of the production of anti-OspA borreliacidal antibody with T cells from hamsters vaccinated against Borrelia burgdorferi. Infect Immun. 1998 Apr;66(4):1507-1512. PMCID: PMC108081.
Abstract

Callister SM, Schell RF, Lovrich SD. Enhanced sensitivity of the borreliacidal-antibody test. Mayo Clin Proc. 1997 Nov;72(11):1093-1094 [Comment].

DuChateau BK, Jensen JR, England DM, Callister SM, Lovrich SD, Schell RF. Macrophages and enriched populations of T lymphocytes interact synergistically for the induction of severe, destructive Lyme arthritis. Infect Immun. 1997 Jul;65(7):2829-2836. PMCID: PMC175398.
Abstract

Bakken LL, Callister SM, Wand PJ, Schell RF. Interlaboratory comparison of test results for detection of Lyme disease by 516 participants in the Wisconsin State Laboratory of Hygiene/College of American Pathologists Proficiency Testing program. J Clin Microbiol. 1997 Mar;35(3):537-543. PMCID: PMC229622.
Abstract

Padilla ML, Callister SM, Schell RF, Bryant GL, Jobe DA, Lovrich SD, DuChateau BK, Jensen JR. Characterization of the protective borreliacidal antibody response in humans and hamsters after vaccination with a Borrelia burgdorferi outer surface protein A vaccine. J Infect Dis. 1996 Oct;174(4):739-746.
Abstract

Callister SM, Jobe DA, Schell RF, Pavia CS, Lovrich SD. Sensitivity and specificity of the borreliacidal-antibody test during early Lyme disease: A "gold standard"? Clin Diagn Lab Immunol. 1996 Jul;3(4):399-402. PMCID: PMC170357.
Abstract

DuChateau BK, England DM, Callister SM, Lim LC, Lovrich SD, Schell RF. Macrophages exposed to Borrelia burgdorferi induce Lyme arthritis in hamsters. Infect Immun. 1996 Jul;64(7):2540-2547. PMCID: PMC174108.
Abstract

Nicholls TH, Callister SM. Lyme disease spirochetes in ticks collected from birds in midwestern United States. J Med Entomol. 1996 May;33(3):379-384.
Abstract

Creson JR, Lim LC, Glowacki NJ, Callister SM, Schell RF. Detection of anti-Borrelia burgdorferi antibody responses with the borreliacidal antibody test, indirect fluorescent-antibody assay performed by flow cytometry, and western immunoblotting. Clin Diagn Lab Immunol. 1996 Mar;3(2):184-190. PMCID: PMC170272.
Abstract

Lovrich SD, Callister SM, DuChateau BK, Lim LC, Winfrey J, Day SP, Schell RF. Abilities of OspA proteins from different seroprotective groups of Borrelia burgdorferi to protect hamsters from infection. Infect Immun. 1995 Jun;63(6):2113-2119. PMCID: PMC173274.
Abstract

Callister SM, Schell RF. Importance of protective borreliacidal antibodies in Lyme disease immunity and serodiagnosis. J Infect Dis. 1994 Aug;170(2):499-500.

Lovrich SD, Callister SM, Lim LC, DuChateau BK, Schell RF. Seroprotective groups of Lyme borreliosis spirochetes from North America and Europe. J Infect Dis. 1994 Jul;170(1):115-121.
Abstract

Callister SM, Schell RF, Lim LC, Jobe DA, Case KL, Bryant GL, Molling PE. Detection of borreliacidal antibodies by flow cytometry. An accurate, highly specific serodiagnostic test for Lyme disease. Arch Intern Med. 1994 Jul 25;154(14):1625-1632.
Abstract

Lim LC, England DM, DuChateau BK, Glowacki NJ, Creson JR, Lovrich SD, Callister SM, Jobe DA, Schell RF. Development of destructive arthritis in vaccinated hamsters challenged with Borrelia burgdorferi. Infect Immun. 1994 Jul;62(7):2825-2833.
Abstract

Liu YF, Lim LC, Schell K, Lovrich SD, Callister SM, Schell RF. Differentiation of borreliacidal activity caused by immune serum or antimicrobial agents by flow cytometry. Clin Diagn Lab Immunol. 1994 Mar;1(2):145-149. PMCID: PMC368217.
Abstract

Jobe DA, Callister SM, Lim LC, Lovrich SD, Schell RF. Ability of canine Lyme disease vaccine to protect hamsters against infection with several isolates of Borrelia burgdorferi. J Clin Microbiol. 1994 Mar;32(3):618-622. PMCID: PMC263096.
Abstract

Lim LC, Liu YF, Schell K, Lovrich SD, Callister SM, Schell RF. Detection of borreliacidal antibody by using acridine orange and flow cytometry. Clin Diagn Lab Immunol. 1994 Jan;1(1):44-50. PMCID: PMC368194.
Abstract

Callister SM, Schell RF, Lovrich SD, Jobe DA. Lyme disease: laboratory diagnosis and serologic testing. Endeavour. 1994;18(2):80-84.
Abstract

Lovrich SD, Callister SM, Lim LC, Schell RF. Seroprotective groups among isolates of Borrelia burgdorferi. Infect Immun. 1993 Oct;61(10):4367-4374. PMCID: PMC281168.
Abstract

Jobe DA, Callister SM, Schell RF. Recovery of Borrelia burgdorferi by filtration. J Clin Microbiol. 1993 Jul;31(7):1896-1898. PMCID: PMC265653.
Abstract

Callister SM, Schell RF, Case KL, Lovrich SD, Day SP. Characterization of the borreliacidal antibody response to Borrelia burgdorferi in humans: A serodiagnostic test. J Infect Dis. 1993 Jan;167(1):158-164.
Abstract

Bakken LL, Case KL, Callister SM, Bourdeau NJ, Schell RF. Performance of 45 laboratories participating in a proficiency testing program for Lyme disease serology. JAMA. 1992 Aug 19;268(7):891-895.
Abstract

Agger WA, Callister SM, Jobe DA. In vitro susceptibilities of Borrelia burgdorferi to five oral cephalosporins and ceftriaxone. Antimicrob Agents Chemother. 1992 Aug;36(8):1788-1790. PMCID: PMC192050.
Abstract

Schmitz JL, Schell RF, Callister SM, Lovrich SD, Day SP, Coe JE. Immunoglobulin G2 confers protection against Borrelia burgdorferi infection in LSH hamsters. Infect Immun. 1992 Jul;60(7):2677-2682. PMCID: PMC257220.
Abstract

Sachsenmeier KF, Schell K, Morrissey LW, Pennell DR, West RM, Callister SM, Schell RF. Detection of borreliacidal antibodies in hamsters by using flow cytometry. J Clin Microbiol. 1992 Jun;30(6):1457-1461. PMCID: PMC265310.
Abstract

Schmitz JL, Lovrich SD, Callister SM, Schell RF. Depletion of complement and effects on passive transfer of resistance to infection with Borrelia burgdorferi. Infect Immun. 1991 Oct;59(10):3815-3818. PMCID: PMC258956.
Abstract

Callister SM, Schell RF, Lovrich SD. Lyme disease assay which detects killed Borrelia burgdorferi. J Clin Microbiol. 1991 Sep;29(9):1773-1776. PMCID: PMC270208.
Abstract

Lovrich SD, Callister SM, Schmitz JL, Alder JD, Schell RF. Borreliacidal activity of sera from hamsters infected with the Lyme disease spirochete. Infect Immun. 1991 Aug;59(8):2522-2528. PMCID: PMC258050.
Abstract

Nelson JA, Bouseman JK, Kitron U, Callister SM, Harrison B, Bankowski MJ, Peeples ME, Newton BJ, Anderson JF. Isolation and characterization of Borrelia burgdorferi from Illinois Ixodes dammini. J Clin Microbiol. 1991 Aug;29(8):1732-1734. PMCID: PMC270194.
Abstract

Schmitz JL, Schell RF, Lovrich SD, Callister SM, Coe JE. Characterization of the protective antibody response to Borrelia burgdorferi in experimentally infected LSH hamsters. Infect Immun. 1991 Jun;59(6):1916-1921. PMCID: PMC257943.
Abstract

Agger WA, Case KL, Bryant GL, Callister SM. Lyme disease: Clinical features, classification, and epidemiology in the upper Midwest. Medicine (Baltimore). 1991 Mar;70(2):83-90.
Abstract

Callister SM, Nelson JA, Schell RF, Jobe DA, Bautz R, Agger WA, Coggins J. Survey for Ixodes spp. and Borrelia burgdorferi in southeastern Wisconsin and northeastern Illinois. J Clin Microbiol. 1991 Feb;29(2):403-406. PMCID: PMC269778.
Abstract

Callister SM, Case KL, Agger WA, Schell RF, Johnson RC, Ellingson JL. Effects of bovine serum albumin on the ability of Barbour-Stoenner-Kelly medium to detect Borrelia burgdorferi. J Clin Microbiol. 1990 Feb;28(2):363-365. PMCID: PMC269609.
Abstract

Hejka A, Schmitz JL, England DM, Callister SM, Schell RF. Histopathology of Lyme arthritis in LSH hamsters. Am J Pathol. 1989 May;134(5):1113-1123. PMCID: PMC1879892.
Abstract

Callister SM, Agger WA, Schell RF, Brand KM. Efficacy of the urinary bladder for isolation of Borrelia burgdorferi from naturally infected, wild Peromyscus leucopus. J Clin Microbiol. 1989 Apr;27(4):773-774. PMCID: PMC267416.
Abstract

Callister SM, Agger WA, Schell RF, Ellingson JL. Borrelia burgdorferi infection surrounding La Crosse, Wis. J Clin Microbiol. 1988 Dec;26(12):2632-2636. PMCID: PMC266960.
Abstract

Back to Top